Arnhold LLC’s Biogen BIIB Stock Holding History

Arnhold LLC’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-3,900	Closed	-$1.13M	–	136
2018 Q2	$1.13M	Buy	+3,900	New	+$1.1M	0.2%	92

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Arnhold LLC's BIIB Position: Q3 2018 in Review

Arnhold LLC sold out of Biogen (BIIB) in Q3 2018, closing a stake of 3,900 shares — an estimated $1.13M sold.

Arnhold LLC first reported a position in BIIB in Q2 2018 and held it in 1 quarter. The position peaked at $1.13M in Q2 2018. 1,145 funds tracked by Wall St. Rank hold BIIB as of Q3 2018.

Arnhold LLC reported no remaining Biogen position as of Q3 2018 after selling out during the quarter.
Arnhold LLC sold 3,900 Biogen shares in Q3 2018, an estimated $1.13M.
Arnhold LLC first reported a position in Biogen in Q2 2018 and held it in 1 quarter.
Arnhold LLC's Biogen position peaked at $1.13M in Q2 2018.
1,145 funds tracked by Wall St. Rank held Biogen as of Q3 2018.

Based on Arnhold LLC's 13F filing for Q3 2018, filed 6 Nov 2018.